mxe002

Masumi Eto, PhD

Contact Dr. Eto

1020 Locust Street
436 JAH
Philadelphia, PA 19107

(215) 503-7891
(215) 503-2073 fax

Most Recent Peer-reviewed Publications

  1. Protein phosphatases 1 and 2A and their naturally occurring inhibitors: current topics in smooth muscle physiology and chemical biology
  2. Unfair competition governs the interaction of pCPI-17 with myosin phosphatase (PP1-MYPT1)
  3. Diversity and plasticity in signaling pathways that regulate smooth muscle responsiveness: Paradigms and paradoxes for the myosin phosphatase, the master regulator of smooth muscle contraction
  4. F-actin clustering and cell dysmotility induced by the pathological W148R missense mutation of filamin B at the actin-binding domain
  5. Reconstituted human myosin light chain phosphatase reveals distinct roles of two inhibitory phosphorylation sites of the regulatory subunit, MYPT1
  6. Nuclear localization of CPI-17, a protein phosphatase-1 inhibitor protein, affects histone H3 phosphorylation and corresponds to proliferation of cancer and smooth muscle cells
  7. Endogenous inhibitor proteins that connect Ser/Thr kinases and phosphatases in cell signaling
  8. Caffeine relaxes smooth muscle through actin depolymerization
  9. Reciprocal regulation controlling the expression of CPI-17, a specific inhibitor protein for the myosin light chain phosphatase in vascular smooth muscle cells
  10. Molecular mechanism of telokin-mediated disinhibition of myosin light chain phosphatase and cAMP/cGMP-induced relaxation of gastrointestinal smooth muscle
  11. Interleukin 6 mediates production of interleukin 10 in metastatic melanoma
  12. Effects of a fluorescent myosin light chain phosphatase inhibitor on prostate cancer cells
  13. Heat shock augments angiotensin II-induced vascular contraction through increased production of reactive oxygen species
  14. Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 Inhibitors
  15. Solution structure of the inhibitory phosphorylation domain of myosin phosphatase targeting subunit 1
  16. ROCK mediates phorbol ester-induced apoptosis in prostate cancer cells via p21 Cip1 up-regulation and JNK
  17. Phosphorylation-dependent autoinhibition of myosin light chain phosphatase accounts for Ca2+ sensitization force of smooth muscle contraction
  18. Expression of CPI-17 in smooth muscle during embryonic development and in neointimal lesion formation
  19. Nitric oxide-induced biphasic mechanism of vascular relaxation via dephosphorylation of CPI-17 and MYPT1
  20. Y27632, a Rho-activated kinase inhibitor, normalizes dysregulation in alpha1-adrenergic receptor-induced contraction of Lyon hypertensive rat artery smooth muscle